ABOUT THE PRODUCT
OGSIVEO® (nirogacestat) is a gamma secretase inhibitor approved for the treatment of adults with desmoid tumors and for both adults and children with neurofibromatosis type 1 associated plexiform neurofibromas (NF1-PN).
Information is owner-confirmed
Last updated 4 months ago
Price range
Other products/services from SpringWorks Therapeutics
EZMEKLY® (mirdametinib)
Biotechnology
N/A
SpringWorks Therapeutics
United States (US)